Science and Technology

Public Policy on the Technological Frontier

This article can be found in Chapter Four of the book, "The Growing Gap Between Emerging Technologies and Legal-Ethical Oversight: The Pacing Problem."  Click here for the link. 

 

Canadian Astronaut Reflects on Space Missions

Looking at Earth from space is like "seeing a blue marble in a black drop of darkness," said Julie Payette, a Canadian astronaut who is spending six months in residence as a Wilson Center public policy scholar. Payette is one of only four astronauts in Canada.

PEN 19 - Voluntary Initiatives, Regulation, and Nanotechnology Oversight

Enough voluntary initiatives for nanotechnology have been implemented so they can be looked at together, in a comparative sense, and historically, in terms of their relationship to programs that have preceded them. This report provides that analysis for the first time. In Voluntary Initiatives, Regulation, and Nanotechnology Oversight: Charting a Path, Dr.

Synthetic Biology Newsletter 2.0

This July 2011 issue of Synthetic Biology 2.0 looks at the work of the United States Presidential Bioethics Commission, the dominant discourse in the synthetic biology debate, vaccines as the first commercial applicaiton of synthetic biology, do-it-yourself biology, biosecurity, and biofiction where science and arts meet.

Trends in American & European Press Coverage of Synthetic Biology

The increase in media coverage of synthetic biology between 2003-2008 is tracked in this 2008 report. The combined survey rests on the findings of individual U.S. and European press coverage analyses, and examines aspects of synthetic biology that may be cause for either potential public acceptance or rejection of the technology. The report concludes with an agenda for future social science research that can inform our understanding of how public perceptions of synthetic biology develop.

New Life, Old Bottles

In New Life, Old Bottles: Regulating First-Generation Products of Synthetic Biology, Michael Rodemeyer examines the benefits and drawbacks of using the existing U.S. regulatory framework for biotechnology to cover the new products and processes enabled by synthetic biology. The safety of early applications of synthetic biology may be adequately addressed by the existing regulatory framework for biotechnology, especially in contained laboratories and manufacturing facilities, according to the report.

Nanotechnology, Synthetic Biology, & Public Opinion

A groundbreaking poll of 1,001 U.S. adults conducted by Peter D. Hart Research Associates and the Project on Emerging Nanotechnologies found 90 percent of Americans think that the public should be better informed about the development of cutting-edge technologies, according to this 2009 report summarizing the findings. 

Pages